Organogenesis holdings inc. (ORGO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Mar'16
Cash flows from operating activities:
Net loss

-16,313

-4,398

-10,741

-9,649

-15,666

-9,255

-13,078

-20,010

-22,488

-5,929

-2,117

380

140

-15

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation

902

835

792

859

902

701

861

875

872

-

-

-

-

-

Amortization of intangible assets

817

1,517

1,529

1,499

1,498

917

918

917

917

-

-

-

-

-

Non-cash interest expense

46

47

42

39

115

250

250

106

239

-

-

-

-

-

Deferred interest expense

470

472

1,510

-572

36

70

290

-131

20

-

-

-

-

-

Deferred rent expense

92

276

280

277

49

14

14

14

14

-

-

-

-

-

Gain on settlement of deferred acquisition consideration

1,295

-

-

-

-

-

-

-

-

-

-

-

-

-

Write-off of deferred offering costs

-

-

-

-

-

-

-

3,494

-

-

-

-

-

-

Provision (benefit) recorded for sales returns and doubtful accounts

217

268

-56

103

-76

1,176

289

-100

-208

-

-

-

-

-

Loss on disposal of property and equipment

-201

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustment for excess and obsolete inventories

-769

-

-

-

-257

-

-

-

-

-

-

-

-

-

Provision recorded for inventory reserve

-

-

-

-

-

405

235

351

1,482

-

-

-

-

-

Stock-based compensation

209

236

242

234

224

255

252

251

317

-

-

-

-

-

Change in fair value of warrant liability

-

-

-

-

-

170

50

176

73

-

-

-

-

-

Loss on extinguishment of debt

-

0

0

0

-1,862

-

-

-

-

-

-

-

-

-

Changes in fair value of forfeiture rights

-

-

-

-

-

0

0

0

589

-

-

-

-

-

Changes in operating assets and liabilities:
Accrued interest/dividends receivable held in Trust Account

-

-

-

-

-

-

-

-

-

-

-546

227

359

-

Accounts receivable

-6,325

5,244

170

1,751

-2,474

6,295

6,157

2,205

-7,547

-

-

-

-

0

Inventory

4,287

3,223

1,753

1,011

5,076

1,669

-1,793

-634

2,282

-

-

-

-

-

Prepaid expenses and other current assets

2,099

-74

-86

-178

963

-1,251

808

505

1,352

-

-

-

-

-

Accounts payable

-1,910

-648

3,875

-3,409

4,882

448

-7,725

-2,489

9,706

-

-

-

-

-

Accrued expenses and other current liabilities

-1,274

2,857

-37

-54

176

3,029

-1,199

1,313

-789

-

-

-

-

-

Accrued interest - affiliate debt

-

-

-

-

-

12,100

-1,082

-980

-797

-

-

-

-

-

Other liabilities

-153

-215

-266

-197

-252

-262

164

285

129

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

-

-

-

-

-74

-77

-2

-

Accrued expenses

-

-

-

-

-

-

-

-

-

-

2,610

-54

90

15

Net cash used in operating activities

-17,283

-6,401

-5,453

-12,116

-9,558

-17,405

-22,992

-15,781

-4,457

-2,998

-168

-199

-126

-0

Cash flows from investing activities:
Purchases of property and equipment

4,243

3,458

1,275

934

317

362

938

492

65

-

-

-

-

-

Net cash used in investing activities

-4,243

-3,458

-1,275

-1,184

-317

-362

-937

-492

-65

-

-

-

-

-

Cash flows from financing activities:
Line of credit borrowings

-

0

0

2,500

4,500

6,250

-2,211

1,752

3,075

-

-

-

-

-

Payment of equity issuance costs

-

-

-

-

-

-

-

-

-

-

0

0

427

20

Proceeds from term loan

10,000

-

10,000

0

40,000

-

-

-

-

-

-

-

-

-

Repayment of notes payable

-

0

0

0

17,585

0

0

0

10

-

-

-

-

-

Proceeds from the exercise of stock options

816

-

-

-

-

8

33

34

44

-

-

-

-

-

Redemption of redeemable common stock placed into treasury

-

0

0

0

6,762

-

-

-

-

-

-

-

-

-

Principal repayments of capital lease obligations

544

403

306

348

209

87

0

-1

18

-

-

-

-

-

Payment of deferred acquisition consideration

2,042

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

-

0

75

38

811

0

46

122

9

-

-

-

-

-

Net cash provided by financing activities

8,230

47,070

9,728

2,796

19,133

13,285

48,506

16,665

3,082

19,294

0

0

-427

-20

Change in cash and restricted cash

-13,296

37,211

3,000

-10,504

9,258

-4,482

24,577

392

-1,440

1,422

-168

-199

-553

-20

Supplemental disclosure of cash flow information:
Cash paid for interest

2,244

2,226

2,032

1,928

1,962

1,611

1,305

317

2,190

-

-

-

-

-

Cash paid for income taxes

0

-61

43

9

58

-54

0

61

1

-

-

-

-

-

Supplemental disclosure of non-cash investing and financing activities:
Debt issuance costs included in accounts payable

-

446

16

-38

113

-

-

-

-

-

-

-

-

-

Purchases of property and equipment included in accounts payable and accrued expenses

2,942

316

2,060

1,223

415

133

-490

-186

715

-

-

-

-

-

Exercise of common stock warrants included in prepaid expenses and other current assets

-

-

-

-

628

-

-

-

-

-

-

-

-

-

Change in ordinary shares subject to possible redemption

-

-

-

-

-

-

-

-

-

-

-2,117

380

140

-